73 related articles for article (PubMed ID: 36230895)
1. Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.
Gao J; Ren S; Choonoo G; Chen G; Frleta D; Zhong J; Gupta N; Sharma P; Oyejide A; Atwal GS; Macdonald L; Murphy A; Kuhnert F
Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37718909
[TBL] [Abstract][Full Text] [Related]
2. "Next top" mouse models advancing CTCL research.
Luo Y; de Gruijl FR; Vermeer MH; Tensen CP
Front Cell Dev Biol; 2024; 12():1372881. PubMed ID: 38665428
[TBL] [Abstract][Full Text] [Related]
3. Killing of
Aguirre-Botero MC; Aliprandini E; Gladston A; Pacios O; Miyazawa Martins R; Poyet JL; Amino R
Microorganisms; 2024 Feb; 12(3):. PubMed ID: 38543531
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate.
Abbas H; Derkaoui DK; Jeammet L; Adicéam E; Tiollier J; Sicard H; Braun T; Poyet JL
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38275765
[TBL] [Abstract][Full Text] [Related]
5. [New developments in Sézary syndrome].
Caudron A; Marie-Cardine A; Bensussan A; Bagot M
Ann Dermatol Venereol; 2012 Jan; 139(1):31-40. PubMed ID: 22225740
[TBL] [Abstract][Full Text] [Related]
6. Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model.
Habault J; Thonnart N; Ram-Wolff C; Bagot M; Bensussan A; Poyet JL; Marie-Cardine A
Cells; 2022 Sep; 11(19):. PubMed ID: 36230895
[TBL] [Abstract][Full Text] [Related]
7. A novel mouse model for Sézary syndrome using xenotransplantation of Sézary cells into immunodeficient RAG2(-/-) γc(-/-) mice.
van der Fits L; Rebel HG; Out-Luiting JJ; Pouw SM; Smit F; Vermeer KG; van Zijl L; Tensen CP; Weijer K; Vermeer MH
Exp Dermatol; 2012 Sep; 21(9):706-9. PubMed ID: 22897578
[TBL] [Abstract][Full Text] [Related]
8. Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity.
Poglio S; Prochazkova-Carlotti M; Cherrier F; Gros A; Laharanne E; Pham-Ledard A; Beylot-Barry M; Merlio JP
Leukemia; 2021 Jun; 35(6):1696-1709. PubMed ID: 33106625
[TBL] [Abstract][Full Text] [Related]
9. Sézary syndrome patient-derived models allow drug selection for personalized therapy.
Gallardo F; Andrades E; Iglesias A; González J; Solé L; Guillén Y; Blanco G; Colomo L; Gimeno E; Conde D; Rodriguez E; Bielsa-Marso I; Iglesias M; Bellosillo B; Pujol RM; Regueiro JR; Bigas A; Espinosa L
Blood Adv; 2022 Jun; 6(11):3410-3421. PubMed ID: 35413113
[TBL] [Abstract][Full Text] [Related]
10. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.
Gill RPK; Gantchev J; Martínez Villarreal A; Ramchatesingh B; Netchiporouk E; Akilov OE; Ødum N; Gniadecki R; Koralov SB; Litvinov IV
Cells; 2022 Feb; 11(4):. PubMed ID: 35203244
[TBL] [Abstract][Full Text] [Related]
11. The role of cell-penetrating peptides in potential anti-cancer therapy.
Zhou M; Zou X; Cheng K; Zhong S; Su Y; Wu T; Tao Y; Cong L; Yan B; Jiang Y
Clin Transl Med; 2022 May; 12(5):e822. PubMed ID: 35593206
[TBL] [Abstract][Full Text] [Related]
12. Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome.
Roelens M; de Masson A; Andrillon A; Ram-Wolff C; Biard L; Boisson M; Mourah S; Battistella M; Toubert A; Bagot M; Moins-Teisserenc H
Br J Dermatol; 2022 Jun; 186(6):1010-1025. PubMed ID: 35041763
[TBL] [Abstract][Full Text] [Related]
13. PAK1-Dependent Antitumor Effect of AAC-11‒Derived Peptides on Sézary Syndrome Malignant CD4
Habault J; Thonnart N; Pasquereau-Kotula E; Bagot M; Bensussan A; Villoutreix BO; Marie-Cardine A; Poyet JL
J Invest Dermatol; 2021 Sep; 141(9):2261-2271.e5. PubMed ID: 33745910
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
